Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Not yet recruiting × Oligodendroglioma × Eflornithine × Clear all

Phase

Status

Not yet recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Lymphoid 1 CNS 1

Conditions

Sarcoma, Ewing 1 Osteosarcoma 1 Oligodendroglioma 1 Lymphoma, Follicular 1 Glioma 1 Glioblastoma 1 Astrocytoma 1

Interventions

Transurethral Resection of Bladder 1 Spinal Puncture 1 Specimen Handling 1 Magnetic Resonance Spectroscopy 1 Eflornithine 1 Anthropogenic Effects 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT07468136 2026-04-13

Retifanlimab With or Without Difluoromethylornithine for the Treatment of Progressive High Grade Gliomas

Mayo Clinic

Phase 1/2 Not yet recruiting

Astrocytoma, Glioblastoma, Glioma, Lymphoma, Follicular, Oligodendroglioma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡